Asciminib Products | Cleanchem - Asciminib is a targeted therapy for chronic myeloid leukemia (CML), specifically in cases with resistance to other treatments. It is a STAMP (Specifically Targeting the ABL Myristoyl Pocket) inhibitor that binds to a unique site on the BCR-ABL1 fusion protein. This offers a novel mechanism compared to traditional tyrosine kinase inhibitors. It has shown promise in T315I-mutated CML cases.